Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical synthesis, biological activities and action on nuclear receptors of 20S(OH)D3, 20S,25(OH)2D3, 20S,23S(OH)2D3 and 20S,23R(OH)2D3. | Bioorg Chem | 2022 | 35168121 | PubTator, text mining | PubMed |
| The Human Microbiota and Skin Cancer. | Int J Mol Sci | 2022 | 35163734 | PubTator, text mining | PubMed |
| Carboxamide Derivatives Are Potential Therapeutic AHR Ligands for Restoring IL-4 Mediated Repression of Epidermal Differentiation Proteins. | Int J Mol Sci | 2022 | 35163694 | PubTator, text mining | PubMed |
| Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential. | Int J Mol Sci | 2022 | 35163615 | PubTator, text mining | PubMed |
| Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View. | Int J Mol Sci | 2022 | 35163222 | PubTator, text mining | PubMed |
| Cholesterol sulfate fluidizes the sterol fraction of the stratum corneum lipid phase and increases its permeability. | J Lipid Res | 2022 | 35143845 | PubTator, text mining | PubMed |
| Changes in levels of omega-O-acylceramides and related processing enzymes of sun-exposed and sun-protected facial stratum corneum in differently pigmented ethnic groups. | Int J Cosmet Sci | 2022 | 35141910 | PubTator, text mining | PubMed |
| IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker. | Front Immunol | 2022 | 35140724 | PubTator, text mining | PubMed |
| A review of alternative methods to the use of animals in safety evaluation of cosmetics. | Einstein (Sao Paulo) | 2022 | 35137796 | PubTator, text mining | PubMed |
| Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling. | Semin Cell Dev Biol | 2022 | 35131152 | PubTator, text mining | PubMed |
| Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes. | Front Immunol | 2022 | 35126391 | PubTator, text mining | PubMed |
| Novel nanofibrous membrane-supporting stem cell sheets for plasmid delivery and cell activation to accelerate wound healing. | Bioeng Transl Med | 2022 | 35111946 | PubTator, text mining | PubMed |
| CD73+ Epithelial Progenitor Cells That Contribute to Homeostasis and Renewal Are Depleted in Eosinophilic Esophagitis. | Cell Mol Gastroenterol Hepatol | 2022 | 35108658 | PubTator, text mining | PubMed |
| Flare management in atopic dermatitis: from definition to treatment. | Ther Adv Chronic Dis | 2022 | 35070252 | PubTator, text mining | PubMed |
| Host-Microbe Interaction on the Skin and Its Role in the Pathogenesis and Treatment of Atopic Dermatitis. | Pathogens | 2022 | 35056019 | PubTator, text mining | PubMed |
| Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis. | Int J Mol Sci | 2022 | 35054979 | PubTator, text mining | PubMed |
| Konjac Ceramide (kCer)-Mediated Signal Transduction of the Sema3A Pathway Promotes HaCaT Keratinocyte Differentiation. | Biology (Basel) | 2022 | 35053118 | PubTator, text mining | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
| The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa. | Inflammation | 2022 | 35044570 | PubTator, text mining | PubMed |
| Tissue engineering strategies to bioengineer the ageing skin phenotype in vitro. | Aging Cell | 2022 | 35037366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=35